Genomic and Epigenomic Biomarkers of Toxicology and Disease. Группа авторов

cancer biomarkers.

      14 Chapter 13Table 13.1 Genetic alterations as biomarkers.

      15 Chapter 13Table 13.2 SMYD overexpression as biomarker.

      16 Chapter 13Table 13.3 SMYD3-mediated histone lysine methylation as biomarker.

      17 Chapter 13Table 13.4 Non-histone lysine methylation as biomarker.

      18 Chapter 14Table 14.1 Summary of the main risk factors...

      19 Chapter 14Table 14.2 Types of immunotherapies currently...

      20 Chapter 15Table 15.1 DMTs subtypes and their function.

      21 Chapter 15Table 15.2 Epigenetic interference of food...

      22 Chapter 16Table 16.1 Toxic effects associated to...

      23 Chapter 17Table 17.1 List of candidate genes involved in the...

      24 Chapter 18Table 18.1 Summary of differentially methylated clusters.

      25 Chapter 20Table 20.1 A summary of selected nanomaterial...

      26 Chapter 20Table 20.2 Hallmark features of nanoparticle...

      Guide

      1  Cover

      2  Title page

      3  Copyright

      4  Dedication

      5 Table of Contents

      6  Preface

      7  Acknowledgements

      8  List of Contributors

      9  Begin Reading

      10  Index

      11  End User License Agreement

      Pages

      1  i

      2  ii

      3  iii

      4  iv

      5  v

      6  vi

      7  vii

      8  viii

      9  ix

      10  xi

      11  xiii

      12  xv

      13  xvi

      14  xvii

      15  xviii

      16  1

      17  2

      18  3

      19  4

      20 5

      21 6

      22  7

      23  8

      24  9

      25  10

      26  11

      27  12

      28  13

      29  14

      30  15

      31 16

      32 17

      33  18

      34  19

      35  20

      36  21

      37  22

      38  23

      39  24

      40 25

      41 26

      42 27

      43 28

      44 29

      45 30

      46 31

      47 32

      48 33

      49 34

      50 35

      51 36

      52  37

      53  38